In summary, our comprehensive analysis of ZNRF2 in pancancer cases reveals a high expression of ZNRF2 in many human tumours, along with a statistical correlation between ZNRF2 expression levels and patient survival, protein phosphorylation, immune cell infiltration, tumour mutational burden or microsatellite instability and mTOR signalling pathway. Here, MTOR is linked to neoplasm.